# Hatch BioFund Management

Hatch BioFund Management is a Private Equity based in Philadelphia region, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Philadelphia region, United States
- **Region:** North America
- **Address:** Doylestown, PA, United States
- **Assets under management:** Undisclosed
- **Website:** www.hatchbiofund.com
- **LinkedIn:** https://www.linkedin.com/company/hatchbiofund

## Regulatory record

- **CRD number:** 330746
- **SEC file number:** 802-130242
- **Registration status:** ACTIVE
- **Latest Form ADV filing:** 2026-03-23T05:00:00.000Z
- **Reports private funds:** Yes
- **Private funds reported:** 0
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/330746

## About

Hatch Biofund is a life sciences venture capital firm headquartered in the Philadelphia region. It provides early-stage capital to promising life science companies, along with access to deep industry expertise and physical platforms. The firm takes an active role in its investments and puts collaboration at the center of supporting entrepreneurs working on life-changing scientific solutions.

## Sectors

- Digital Health
- Healthcare Services
- Enterprise Software

## People

- Lorenzo Pellegrini — Ph.D., Managing Partner
- Louis P. Kassa III — MPA, Founder and Advisor
- Timothy M. Block — Ph.D., Founder and Advisor

## Questions

### What is the core investment strategy at Hatch BioFund Management?

Hatch BioFund focuses on early-stage life-science and health-technology companies, committing capital at seed and start-up rounds and following on through expansion when portfolio companies meet clinical or regulatory milestones. The firm invests across therapeutics, medical devices, diagnostics, and digital-health platforms. Its model is built on direct equity positions rather than fund-of-funds commitments, and it operates with a sector-concentrated mandate that excludes generalist technology or consumer investments.

### Does Hatch BioFund co-invest alongside other venture firms?

The firm participates in syndicated rounds with other specialist healthcare investors, particularly those active in the Northeast corridor and major US biotech clusters. Its typical co-investor set includes other life-science-focused venture firms with deep domain expertise, enabling shared diligence on scientific claims and regulatory pathways. Hatch BioFund does not operate as a solo underwriter for the majority of its deals.

### What stage does Hatch BioFund Management target?

Hatch BioFund targets the earliest stages of company formation — seed and start-up — where capital is scarce and scientific risk is highest. It also participates in expansion and later-stage rounds for portfolio companies that have achieved clinical proof-of-concept or demonstrated a clear FDA pathway. The expansion capital comes from the same committed vehicle rather than a separate growth fund, keeping the firm's incentives aligned across the full company lifecycle.

### Which therapeutic areas does Hatch BioFund specialize in?

The firm invests broadly across life sciences, with confirmed focus areas that include therapeutics, medical devices, diagnostics, and digital-health infrastructure. Hatch BioFund favors companies with intellectual property anchored in university research or founder-led discovery, and its diligence is weighted toward clinical-trial design and regulatory strategy rather than market-sizing exercises.

## Related profiles

- [HATCH](https://altss.com/profile/hatch)
- [Hatcher+](https://altss.com/profile/hatcher)

---

Last updated: 2026-08-11T15:06:57.816Z

Canonical page: https://altss.com/profile/hatch-biofund-management

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology